Scholar Rock Says FDA Review Of Apitegromab BLA Continues; Approval Decision Expected By Sept. 30 | 08.08.26 | finanzen.at
(RTTNews) - Scholar Rock Holding Corp. (SRRK) said Friday the U.S. Food and Drug Administration will continue reviewing the Biologics License Appl...